The management of pre-eclampsia is based around accurate detection of risk, targetting of prophylactic therapies and then prompt intervention. Most deaths occur in low and middle income countries, but when well mananged maternal deaths are very rare. The judicous use of prophylactic aspirin, and the subsequent detection of those at risk are key to success. This allows timely delivery while managing women in a safe environment with prompt access to anti hypertensive medication and anticonvulsants such as Magnesium Sulphate. This talk will discuss the evidence base around new angiogenic markers to identify risk, the use of aspirin and the need for effective monitoring in a global setting. The role of early delivery will also be elucidated.
Learning Objectives:
Objective 1: Appreciate the global impact of pre-eclampsia on maternal and perinatal morbidity and mortality;
Objective 2: Learn the role of aspirin as a prophylactic intervention to those at risk of pre-eclampsia;
Objectives 3: Understand the use of angiogenic markers in identifying and managing women at risk.
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
